nicolas sordet

About nicolas sordet

Nicolas Sordet is the co-founder and Chief Executive Officer of AFYREN, a French green chemistry company focused on producing biosourced organic acids from non-food biomass. He is one of the key architects of the company’s industrial and technological strategy. AFYREN was founded in 2012, and Sordet launched the company with Jérémy Pessiot around a proprietary fermentation platform designed to replace petro-sourced molecules with low-carbon, circular alternatives. The company’s model is built on industrial sustainability, renewable carbon, and the conversion of agricultural co-products into high-value ingredients. As CEO, Nicolas Sordet has overseen AFYREN’s major development milestones: building the R&D platform, expanding the management team, securing funding rounds, advancing industrial scale-up, and bringing AFYREN NEOXY into operation at Carling Saint-Avold in northeastern France. He also played a central role in the company’s capital markets trajectory, including the preparation and execution of AFYREN’s listing on Euronext Growth Paris. In corporate communications and investor relations, he has been the public face of the company, regularly representing AFYREN in strategic announcements and industry-facing events. His professional profile is closely associated with the industrialization of sustainable chemistry in Europe. Sordet’s leadership combines technical ambition with operational execution, which is especially important in a capital-intensive sector requiring long development cycles, regulatory alignment, and strong financing capabilities. Under his leadership, AFYREN has positioned itself across multiple end markets, including food, cosmetics, pharmaceuticals, materials, and specialty chemicals, with a consistent emphasis on renewable, circular, and low-carbon solutions. More broadly, Nicolas Sordet embodies an entrepreneurial approach to industrial greentech: turning scientific innovation into a scalable business model with measurable environmental impact. His name is now closely linked to AFYREN’s emergence as a notable European bioeconomy and green chemistry player, and to the company’s transition from R&D-driven startup to industrial-scale operator.